CHENGDU, China, March 9, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) and Harbour BioMed (HKEX: 02142) today announced that the ...
The Andrew Hillman Grant for Biotech, established under the vision of Andrew Hillman, officially announces the opening of ...
DALLAS, TX, UNITED STATES, May 6, 2026 /EINPresswire.com/ — The Andrew Hillman Grant for Biotech officially opens its 2026 application cycle, offering undergraduate ...
Gene therapy maker uniQure is one step closer to marketing its treatment for Huntington’s disease.
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results